CD274 and colorectal carcinoma: Recently, several clinical studies have released results of the use of chemotherapy combination of bevacizumab and PD-L1 / PD-1 in metastatic CRC patients, which demonstrated that the combination is a promising strategy, indorsing clinically meaningful and durable benefit for MSS CRC patients.